Dr. Clay Siegall is the man with the plan when it comes to cancer research. This phenomenal man is one of the most important figures in the cancer-research community. Cancer has been around for a long time and there has been many advancements throughout the years. As of today, antibody-based therapies have changed the game for the better because these targeted-therapies are saving lives at a much higher rate. Siegall just so happens to the CEO and president of biotech-giant Seattle Genetics. This fine institution produces some of the best cancer-fighting drugs in the world.
Clay Siegall has always has an interest in medicine as well as an interest in advanced technology. While he was in college, his father became ill with this deadly disease. During this point in time, cancer treatment was very harsh on the human body and many of the treatments made the patients feel sicker than the illness itself. Radical surgery and amputation were some of the results that came from these treatments. Siegall knew that there had to be a better way to lessen the side effects while saving lives. Unfortunately, his father passed and this is when Siegall’s vision became evident. This brilliant-minded individual is well-educated thanks to attaining a Ph.D in Genetics from George Washington University. In addition to that, he has a B.S. in Zoology from the University of Maryland. He has also won many industry-related awards throughout the years, and he currently holds up to 15 patents.
Seattle Genetics just so happens to be Siegall’s weapon of choice for fighting cancer. He is the CEO, the president and the founder of this magnificent biotech company. Seattle Genetics produces some of the leading cancer fighting medications. ADCETRIS, the company’s premier medication, has gone on to generate hundreds of millions of dollars since its inception in 2011. All in all, Dr. Clay Siegall is leading by example, and he will continue to do so in the coming years.